Latest filing published 12 Sept 2025 for ANAVEX LIFE SCIENCES CORP., €1.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 39 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +5.6%Entry US$2.87 · Close at T+365 US$3.03
- -7.8%Entry US$3.07 · Close at T+365 US$2.83
- +1.7%Entry US$2.89 · Close at T+365 US$2.94
- +2.7%Entry US$2.93 · Close at T+365 US$3.01
- -40.7%Entry US$4.18 · Close at T+365 US$2.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher U. Missling: trading record in brief
All filings by Christopher U. Missling on record concern Anavex Life Sciences Corp., in the capacity of chief executive. We count 50 filings; the first trade dates from 4 June 2015 and the latest from 11 September 2025.
On the open market, the record shows 39 purchases worth €51k and 3 sales worth €3.4M. The net balance comes to €3.4M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 6 option exercises.
The median purchase comes to €1,342. No cluster: in 26 purchases, no other insider of the company bought within 30 days. Looking at 39 purchases old enough to measure, the stock rose over the following 90 days in 46% of cases; the median change was -5.3%. This is a record of the past, not a forecast.
The record was last updated on 12 September 2025 with a share grant (€1.2M) in Anavex Life Sciences Corp. The last insider purchase was made public on 9 March 2018, 3,166 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher U. Missling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 145,048 shares@ US$9.5812.8% of flowCommon StockSEC:0001731122-25-001246:1
- 187,500 shares@ US$5.04100.0% of flowCommon StockSEC:0001731122-25-001246:0
- 500,000 shares@ US$0.9244.0% of flowCommon StockSEC:0001731122-25-000452:0
- 282,497 shares@ US$9.6327.0% of flowCommon StockSEC:0001731122-25-000452:1
- 73,380 shares@ US$5.113.7% of flowCommon StockSEC:0001731122-24-000552:1
- 73,380 shares@ US$1.329.3% of flowCommon StockSEC:0001731122-24-000552:0
- 268,000 shares@ US$7.9821.1% of flowCommon StockSEC:0001731122-23-001246:1
- 232,000 shares@ US$1.603.7% of flowCommon StockSEC:0001731122-23-001246:2
- 268,000 shares@ US$1.6040.7% of flowCommon StockSEC:0001731122-23-001246:0
- 51,620 shares@ US$26.0038.3% of flowCommon StockSEC:0001731122-21-001127:1
- 51,620 shares@ US$1.325.9% of flowCommon StockSEC:0001731122-21-001127:0
- 1,360 shares@ US$2.920.2% of flowCommon StockSEC:0001615774-18-001744:0Canonical exit: 5 Jun 2018 (T+90)
- 1,450 shares@ US$2.730.2% of flowCommon StockSEC:0001615774-18-001650:0Canonical exit: 4 Jun 2018 (T+90)
- 1,500 shares@ US$2.630.2% of flowCommon StockSEC:0001615774-18-001629:0Canonical exit: 3 Jun 2018 (T+90)
- 1,650 shares@ US$2.410.2% of flowCommon StockSEC:0001615774-18-001587:0Canonical exit: 31 May 2018 (T+90)
- 375 shares@ US$4.390.1% of flowCommon StockSEC:0001615774-17-005929:0Canonical exit: 23 Jan 2018 (T+90)
- 375 shares@ US$4.920.1% of flowCommon StockSEC:0001615774-17-005861:0Canonical exit: 22 Jan 2018 (T+90)
- 375 shares@ US$4.490.1% of flowCommon StockSEC:0001615774-17-005807:0Canonical exit: 17 Jan 2018 (T+90)
- 375 shares@ US$4.270.1% of flowCommon StockSEC:0001615774-17-005767:0Canonical exit: 15 Jan 2018 (T+90)
- 750 shares@ US$4.220.1% of flowCommon StockSEC:0001615774-17-005731:0Canonical exit: 11 Jan 2018 (T+90)
- 375 shares@ US$4.300.1% of flowCommon StockSEC:0001615774-17-005604:0Canonical exit: 3 Jan 2018 (T+90)
- 375 shares@ US$4.200.1% of flowCommon StockSEC:0001615774-17-005508:0Canonical exit: 31 Dec 2017 (T+90)
- 375 shares@ US$4.210.1% of flowCommon StockSEC:0001615774-17-005440:0Canonical exit: 27 Dec 2017 (T+90)
- 375 shares@ US$3.880.1% of flowCommon StockSEC:0001615774-17-005351:0Canonical exit: 25 Dec 2017 (T+90)
- 375 shares@ US$4.230.1% of flowCommon StockSEC:0001615774-17-005226:0Canonical exit: 19 Dec 2017 (T+90)
25 of 50 declarations